CClinicalTrials.gg
CompletedNCT02509819Updated Jan 16, 2019

The Influence of Heel Wedge Properties on Roll-over of the Intrepid Dynamic Exoskeletal Orthosis (IDEO)

An interventional study of Heel Cushion Material Bulk (foam) in Physical Disability, sponsored by Brooke Army Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-16.

Sponsored by Brooke Army Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The Intrepid Dynamic Exoskeletal Orthosis (IDEO) is a type of ankle foot orthosis designed to reduce pain and improve function for individuals with foot/ankle pain and/or weakness. Because the IDEO restricts ankle movement, the geometry and mechanics of the device must be designed to allow for a smooth roll-over as the patient walks with the IDEO. The heel wedge, while not physically part of the IDEO, is an integral part of the IDEO-heel wedge-shoe "system". The goal of this research is to determine how heel wedge properties may contribute to the smoothness of roll-over during gait. Insight into the effects of heel wedge properties on roll-over will help optimize the design of the IDEO-heel wedge-shoe "system" and may produce guidelines for the customization of these features.

Read the detailed description

The proposed study includes a between groups comparison (for Aim 1) and a fully repeated crossover design (for Aim 2). It will be conducted in the Military Performance Lab (MPL) at the Center for the Intrepid (CFI), Brooke Army Medical Center, Joint Base San Antonio (JBSA)Fort Sam Houston, Texas. Subjects who use IDEOs will come to the Military Performance Lab for one test session during which they will walk in standardized shoes with six different heel wedges in random order. Control data will also be collected on able-bodied individuals. Control subjects will also come to the MPL for one test session in which they will walk using the same standardized shoes. For all subjects, biomechanical gait data will be collected as the subjects walk along a walkway in the MPL. This data will be used to calculate roll-over shape, instantaneous radius of curvature, Center of Pressure (COP) velocity, and ankle moment.

02

Conditions studied

  • Physical Disability

Keywords

  • rehabilitation
  • IDEO
03

In context

Lead sponsor

Brooke Army Medical Center is the lead sponsor of 92 studies on the registry; 11 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 2 (25%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

IDEO Group

Inclusion Criteria:

  • DEERS (Defense Enrollment Eligibility Reporting System) eligible patients at the CFI
  • 18 - 55 years old
  • Have a unilateral lower extremity injury resulting in foot/ankle weakness and/or pain
  • Currently using an IDEO
  • Use of the IDEO for greater than two weeks
  • Able to ambulate without an assistive device
  • Able to comply with gait analysis
  • Able to provide written informed consent

Exclusion Criteria:

  • Neurologic, musculoskeletal or other disease state affecting the contralateral limb that limits normal locomotion
  • Spinal cord injury or central nervous system pathology
  • Medical or psychological disease that would preclude safe gait analysis (ex. severe traumatic brain injury, stroke, renal failure, heart disease, severe anemia, etc.)
  • Pain level of 4 or greater on a 0-10 scale
  • Any open wound or infection on the foot
  • Pregnancy

Control Group

Inclusion Criteria:

  • DEERS eligible
  • 18 - 55 years old
  • Have no lower extremity injury which affects normal locomotion
  • Able to comply with gait analysis
  • Able to provide written informed consent

Control Group Exclusion Criteria:

  • Neurologic, musculoskeletal or other disease state that limits normal locomotion
  • Previous lower extremity injury requiring surgery (e.g. anterior cruciate ligament tear, femur fracture, etc) or currently affecting normal locomotion
  • Any pain that affects normal locomotion
  • Any open wound or infection on the foot
  • Spinal cord injury or central nervous system pathology
  • Medical or psychological disease that would preclude safe gait analysis (ex. severe traumatic brain injury, stroke, renal failure, heart disease, severe anemia, etc.)
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Military Performance Lab testing

    Subjects who use IDEOs will come to the Military Performance Lab for one test session during which they will walk in standardized shoes with six different foam heel wedges (Heel Cushion Material Bulk (foam) from Kingsley Manufacturing Company) in random order. Control data will also be collected on able-bodied individuals. Control subjects will also come to the MPL for one test session in which they will walk using the same standardized shoes. For all subjects, biomechanical gait data will be collected as the subjects walk along a walkway in the MPL. This data will be used to calculate roll-over shape, instantaneous radius of curvature, COP velocity, and ankle moment.

    Device: Heel Cushion Material Bulk (foam)

Interventions

  • DeviceHeel Cushion Material Bulk (foam)

    The heel wedge is made of a rubber style urethane foam. Heel wedges of specified heights and durometers will be inserted into the standard shoes, one at a time, during the test session only. The heel wedges used during the test session are made of the same foam as the heel wedges that are used clinically.

06

What researchers measure

Primary outcomes

  1. Roll-over shape

    This will be calculated by determining the COP location in the coordinate system of the shank. The shape will be described by the calculated arc length and best-fit radius of curvature

    Time frame: 2 hours

  2. Instantaneous radius of curvature

    This will be calculated by taking the derivative of the anterior-posterior progression of the COP with respect to the shank angle

    Time frame: 2 hours

  3. COP velocity

    This will be calculated by taking the derivative of the COP anterior-posterior position

    Time frame: 2 hours

  4. Ankle moment

    This will be calculated from the Ground Reaction Force (GRF) vector relative to the ankle joint center

    Time frame: 2 hours

07

Study locations

1 site
  • Brooke Army Medical Center
    San Antonio, Texas 78239, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02509819
Lead sponsor
Brooke Army Medical Center
Responsible party
Andrea J. Ikeda (Research Prosthetist, Brooke Army Medical Center) — Principal investigator
First posted
Jul 28, 2015
Start date
Jul 2015
Primary completion
Apr 25, 2016
Completion
Aug 23, 2017
Last update
Jan 16, 2019

Study contacts

Andrea J Ikeda, MS
principal investigator · Brooke Army Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion